
1 

(1) This Order may be cited as the Prescription Only Medicines (Human Use) Amendment Order 1999 and shall come into force on 22nd April 1999.
(2) In this Order, “the principal Order” means the Prescription Only Medicines (Human Use) Order 1997.
2 
In Schedule 1 to the principal Order (which specifies substances which if included in medicinal products make those products prescription only medicines and exemptions from restrictions on the sale and supply of prescription only medicines)—
(a) in relation to the substance Aspirin, the entries in columns 2, 3 and 5 numbered “(1)” are re-numbered “(2)”, the entry in column 3 numbered “(2)” is re-numbered “(3)”; and, before those entries re-numbered “(2)”, there are inserted the following entries—
 in column 2—“
(1) 75mg”,
 in column 3—“
(1) Non-effervescent tablets and capsules”,
 in column 5—“
(1) The quantity sold or supplied in one container or package shall not exceed 100
 The quantity of non-effervescent tablets, capsules or a combination of both sold or supplied to a person at any one time shall not exceed 100”;
(b) in relation to the substance Beclomethasone Dipropionate, in the entry in column 5, for “5,600 mcg” there is substituted “20,000 mcg”;
(c) in relation to the substance Hydrocortisone, the entry in each of columns 2 and 5 is, and the entries in column 3 are, numbered “(2)”; and, before the entries in columns 2, 3 and 5, there are inserted the following entries—
 in column 2—“
(1) 0.5 per cent”,
 in column 3—“
(1) External
 For use in combination with Nystatin of maximum strength 3.0 per cent for intertrigo
 For use in adults and children not less than 10 years”,
 in column 5—“
(1) Container or package containing not more than 15g of medicinal product”;
(d) in relation to the substance Nystatin, there are inserted the following entries—
 in column 2—“
 3.0 per cent”,
 in column 3—“

 For use in combination with Hydrocortisone of maximum strength 0.5 per cent for intertrigo
 For use in adults and children not less than 10 years”,
 in column 5—“Container or package containing not more than 15g of medicinal product”; and
(e) there is inserted in column 1, at the appropriate place in the alphabetical order of the entries in that column, each of the following substances—“Candesartan Cilexetil”“Lornoxicam”“Losartan Potassium”“Nebivolol Hydrochloride”“Nisoldipine”“Propiverine Hydrochloride”“Quetiapine Fumarate”“Tacalcitol Monohydrate”.
Signed by authority of the Secretary of State for Health
Hayman
Parliamentary Under Secretary of State
Department of Health
24th March 1999Signed by authority of the Secretary of State for Wales
Jon Owen Jones
Parliamentary Under Secretary of State Welsh Office
29th March 1999Signed by authority of the Secretary of State for Scotland
Sam Galbraith
Parliamentary Under Secretary of State Scottish Office
25th March 1999Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on
D. C. Gowdy
Permanent Secretary
30th March 1999.